Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor von García-Sáenz, José Á, Martínez-Jáñez, Noelia, Cubedo, Ricardo, Jerez, Yolanda, Lahuerta, Ainhara, González-Santiago, Santiago, Ferrer, Nieves, Ramos, Manuel, Alonso-Romero, Jose L, Antón, Antonio, Carrasco, Eva, Chen, Jingjing, Neuwirth, Rachel, Galinsky, Kevin, Vincent, Sylvie, Leonard, E Jane, Slamon, Dennis

Volltext

XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-po... von Schmid, Peter, Cortes, Javier, Joaquim, Ana, Jañez, Noelia Martínez, Morales, Serafín, Díaz-Redondo, Tamara, Blau, Sibel, Neven, Patrick, Lemieux, Julie, García-Sáenz, José Ángel, Hart, Lowell, Biyukov, Tsvetan, Baktash, Navid, Massey, Dan, Burris, 3rd, Howard A, Rugo, Hope S

Volltext

Maintained complete response to talazoparib in a BRCA-2 mutated metastatic luminal breast cancer: case report and review of literature von Albarrán, Víctor, Chamorro, Jesús, Pozas, Javier, San Román, María, Rosero, Diana Isabel, Saavedra, Cristina, Gion, María, Cortés, Alfonso, Escalera, Elena, Guerra, Eva, López Miranda, Elena, Fernández Abad, María, Martínez Jañez, Noelia

Volltext

Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial von Salvador Bofill, Javier, Moreno Anton, Fernando, Rodriguez Sanchez, Cesar Augusto, Galve Calvo, Elena, Hernando Melia, Cristina, Ciruelos Gil, Eva Maria, Vidal, Maria, Jiménez-Rodriguez, Begoña, De la Cruz Merino, Luis, Martínez Jañez, Noelia, Villanueva Vazquez, Rafael, de Toro Salas, Ruben, Anton Torres, Antonio, Alvarez Lopez, Isabel Manuela, Gavila Gregori, Joaquin, Quiroga Garcia, Vanesa, Vicente Rubio, Elena, De la Haba-Rodriguez, Juan, Gonzalez-Santiago, Santiago, Diaz Fernandez, Nieves, Barnadas Molins, Agusti, Cantos Sanchez de Ibargüen, Blanca, Delgado Mingorance, Juan Ignacio, Bellet Ezquerra, Meritxell, de Casa, Sonia, Gimeno, Asuncion, Martin, Miguel

Volltext

Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advan... von Tibau, Ariadna, Martínez, M. Teresa, Ramos, Manuel, De La Cruz-Merino, Luis, Santaballa, Ana, O’Connor, Miriam, Martínez-Jañez, Noelia, Moreno, Fernando, Fernández, Isaura, Virizuela, Juan Antonio, Alarcón, Jesús, de La Haba-Rodríguez, Juan, Sánchez-Rovira, Pedro, Albacar, Cinta Rosa, Bueno Muiño, Coralia, Kelly, Catherine, Casas, Maribel, Bezares, Susana, Rosell, Libertad, Albanell, Joan

Volltext

Safety of eribulin as third‐line chemotherapy in HER2‐negative, advanced breast cancer pre‐treated with taxanes and anthracycline: OnSITE study von Manso, Luis, Moreno Antón, Fernando, Izarzugaza Perón, Yann, Delgado Mingorance, Juan I., Borrega García, Pablo, Echarri González, María J., Martínez‐Jañez, Noelia, López‐González, Ana, Olier Garate, Clara, Ballesteros García, Anabel, Chacón López-Muñíz, Ignacio, Ciruelos Gil, Eva, García‐Sáenz, Jose Angel, Paz‐Ares, Luis

Volltext

A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors von Juric, Dejan, Barve, Minal, Vaishampayan, Ulka, Roda, Desamparados, Calvo, Aitana, Jañez, Noelia Martinez, Trigo, Jose, Greystoke, Alastair, Harvey, R. Donald, Olszanski, Anthony J., Opyrchal, Mateusz, Spira, Alexander, Thistlethwaite, Fiona, Jiménez, Begoña, Sappal, Jessica Huck, Kannan, Karuppiah, Riley, Jason, Li, Cheryl, Li, Cong, Gregory, Richard C., Miao, Harry, Wang, Shining

Volltext

Early relapse of inflammatory breast carcinoma treated with lapatinib and capecitabine: Ten years of complete response von Martin Huertas, Roberto, Fernández Abad, María, Corral de la Fuente, Elena, Serrano Domingo, Juan José, Martínez Jáñez, Noelia

Volltext

Myocarditis and carotidynia caused by Granulocyte-Colony stimulating factor administration von Corral de la Fuente, Elena, Barquín Garcia, Arantza, Saavedra Serrano, Cristina, Serrano Domingo, Juan José, Martín Huertas, Roberto, Fernández Abad, María, Martínez Jáñez, Noelia

Volltext

Anti-HER2 Therapy Beyond Second-Line for HER2- Positive Metastatic Breast Cancer: A Short Review and Recommendations for Several Clinical Scenarios from a Spanish Expert Panel von Martínez-Jañez, Noelia, Chacón, Ignacio, de Juan, Ana, Cruz-Merino, Luis, del Barco, Sònia, Fernández, Isaura, García-Teijido, Paula, Gómez-Bernal, Amalia, Plazaola, Arrate, Ponce, José, Servitja, Sonia, Zamora, Pilar

Volltext

Genetic platforms: Do we do what we know? or do we know what we do? von Bernet, Laia, Pla, María Jesús, Martinez Jañez, Noelia

Volltext

A Pilot, Phase II, Randomized, Open‐Label Clinical Trial Comparing the Neurotoxicity of Three Dose Regimens of Nab‐Paclitaxel to That of Solvent‐Based Paclitaxel as the First‐Line... von Ciruelos, Eva, Apellániz‐Ruiz, María, Cantos, Blanca, Martinez‐Jáñez, Noelia, Bueno‐Muiño, Coralia, Echarri, Maria‐Jose, Enrech, Santos, Guerra, Juan‐Antonio, Manso, Luis, Pascual, Tomas, Dominguez, Cristina, Gonzalo, Juan‐Francisco, Sanz, Juan‐Luis, Rodriguez‐Antona, Cristina, Sepúlveda, Juan‐Manuel

Volltext

Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast stu... von Freyer, Gilles, Martinez-Jañez, Noelia, Kukielka-Budny, Bożena, Ulanska, Malgorzata, Bourgeois, Hugues, Muñoz, Montserrat, Morales, Serafin, Calero, Juan Bayo, Cortesi, Laura, Pintér, Tamás, Palácová, Markéta, Cherciu, Nelli, Petru, Edgar, Ettl, Johannes, de Almeida, Cécilia, Villanova, Gustavo, Raymond, Romain, Minh, Christine Ta Thanh, Rodrigues, Ana, Cazzaniga, Marina E.

Volltext

Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study von de Dueñas, Eduardo Martínez, Hernández, Ana Lluch, Zotano, Ángel Guerrero, Carrión, Ramón María Pérez, López-Muñiz, José Ignacio Chacón, Novoa, Silvia Antolín, Rodríguez, Ángela López, Fidalgo, José Alejandro Pérez, Lozano, Jaime Ferrer, Gasión, Octavio Burgués, Carrascal, Eva Carrasco, Capilla, Andrés Hernando, López-Barajas, Isabel Blancas, Mateu, Montserrat Muñoz, de Ceballos Reyna, María Helena López, Ferrando, Amparo Oltra, Jañez, Noelia Martínez, Ballerini, Vicente Carañana, Torres, Antonio Antón, Catalán, Gustavo, Sáenz, José Ángel García, Menjón, Salomón, González-Angulo, Ana María

Volltext

Abstract OT-26-02: Phase III open-label, multicenter, randomized trial of adjuvant palbociclib in combination with endocrine therapy versus endocrine therapy alone for patients wit... von Munzone, Elisabetta, Aebi, Stefan, Jañez, Noelia Martínez, Güth, Uwe, Bellet, Meritxell, Pistilli, Barbara, Balic, Marija, Roschitzki-Voser, Heidi, Regan, Meredith M

Volltext

Adjuvant regimens with trastuzumab administered for small HER2-positive breast cancer in routine clinical practice von Antolín-Novoa, S., Blanco-Campanario, E., Antón, A., Gallegos-Sancho, M. I., Pérez-Carrión, R., Peláez, I., Galán-Brotons, A., de la Cruz-Merino, L., Murías-Rosales, A.

Volltext

Quality of life with palbociclib plus fulvestrant placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced bre... von Ariadna Tibau, M. Teresa Martínez, Manuel Ramos, Luis De La Cruz-Merino, Ana Santaballa, Miriam O’Connor, Noelia Martínez-Jañez, Fernando Moreno, Isaura Fernández, Juan Antonio Virizuela, Jesús Alarcón, Juan de La Haba-Rodríguez, Pedro Sánchez-Rovira, Cinta Rosa Albacar, Coralia Bueno Muiño, Catherine Kelly, Maribel Casas, Susana Bezares, Libertad Rosell, Joan Albanell

Volltext

Evaluation of ERBB2 mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases von Carretero-Barrio, Irene, Caniego-Casas, Tamara, Rosas, Marta, Sánchez, María Concepción, Martínez-Jáñez, Noelia, Chiva, Miguel, Sarrió, David, Moreno-Bueno, Gema, Palacios, José, Pérez-Mies, Belén

Volltext

Critically short telomeres and toxicity of chemotherapy in early breast cancer von Quintela-Fandino, Miguel, Soberon, Nora, Lluch, Ana, Manso, Luis, Calvo, Isabel, Cortes, Javier, Moreno-Antón, Fernando, Gil-Gil, Miguel, Martinez-Jánez, Noelia, Gonzalez-Martin, Antonio, Adrover, Encarna, de Andres, Raquel, Viñas, Gemma, Llombart-Cussac, Antonio, Alba, Emilio, Mouron, Silvana, Guerra, Juan, Bermejo, Begoña, Zamora, Esther, García-Saenz, Jose Angel, Simon, Sonia Pernas, Carrasco, Eva, Escudero, María José, Campo, Ruth, Colomer, Ramón, Blasco, Maria A

Volltext

Abstract OT2-20-01: Rogaratinib, palbociclib and fulvestrant in advanced hormone receptor-positive (HR+), FGFR1/2-positive breast cancer: Phase I trial plus an expansion cohort von Pernas, Sonia, Hernando, Cristina, Bermejo, Begoña, Martinez-Jañez, Noelia, Saenz, Jose A García, Morales, Serafin, Manso, Luis, Silva, Jorge, Guerra, Juan A, Malon, Diego, Mouron, Silvana, Caleiras, Eduardo, Quintela-Fandino, Miguel

Volltext